Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Lentiviral Vectors and Gene Therapy

Lentiviral Vectors and Gene Therapy

Escors, David
Breckpot, Karine
Arce, Frederick

Paperback

Series: Springerbriefs in Biochemistry and Molecular Biology

Medical ReferenceBiologyGenetics

ISBN10: 3034804016
ISBN13: 9783034804011
Publisher: Springer Nature
Published: Mar 23 2012
Pages: 104
Weight: 0.40
Height: 0.20 Width: 6.10 Depth: 9.00
Language: English

Gene therapy was conceived during the early and mid part of the 20th century. At first, it was considered a revolutionary biomedical procedure, which could potentially cure any disease for which the molecular bases were understood. Since then, gene therapy has gone through many stages and has evolved from a nearly unrealistic perspective to a real life application. Clinical efficacy in humans was demonstrated at the beginning of this century after its successful application in small-scale clinical trials to cure severe immunodeficiency in children. However, their successes were overshadowed some time later by the occurrence of vector-related leukaemia in a number of treated children. It is in this context that lentiviral vectors have appeared, with improved efficiency and, possibly, increased biosafety. Very recently, the first clinical trials with lentivectors have been carried out with some success.

Also in

Genetics

View All